Dr. Steven Quay, MD, PhD, physician-scientist and CEO of Atossa Therapeutics, Inc. announced today that he

Physician-Scientist Dr. Steven Quay, MD, PhD vows to make the book available through his website...

Dr. Quay announces availability of his COVID-19 Survival Manual on June 5th SEATTLE, May 29, 2020 (GLOBENEWSWIRE) - Dr. Steven...

Results Support Development of AT-H201 for COVID-19 Patients. SEATTLE, May 20, 2020 (GLOBE NEWSWIRE)

Study Designed to Evaluate Atossa's Combination Therapy AT-H201 to Reduce Patient Time on a Ventilator

SEATTLE — The fatality rate for COVID-19 victims on ventilators has been 50% or higher. So, at Atossa Therapeutics in...

The COVID-19 HOPE trial is the first pharmaceutical study to address getting patients off mechanical ventilator and reducing the high...

U.S. Physician Scientist Dr. Steven Quay, MD, PhD offers his predictions based on Coronavirus case growth model